AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Zydus Lifesciences Subsidiary Ampliman 2 Dissolved Without Liquidation

Zydus Lifesciences Limited

AI Sentiment Analysis

January 10, 2026, 08:41 AM

Top Queries to Ask About Zydus Lifesciences Limited

Thinking to buy or sell Zydus Lifesciences Limited? Ask AI before you act.

Users

Trusted by 5,000+ users

More Details on This News

Zydus Lifesciences Limited announced the dissolution of its subsidiary, Ampliman 2, located in France. The dissolution was effective January 9, 2026, and occurred without liquidation.

Ampliman 2 was a wholly owned subsidiary of Zydus MedTech (France) S.A.S., which itself is a step-down wholly owned subsidiary of Zydus Lifesciences Limited. Following the dissolution, all assets and liabilities of Ampliman 2 have been transferred to Zydus MedTech (France) S.A.S.

The company has stated that this dissolution will not have any impact on its overall business operations.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Zydus Lifesciences Limited

Analyze Zydus Lifesciences Limited

Discover more trending news on Prysm

View All